Julia Tejero-Aranguren

Julia Tejero-Aranguren

Auto-generated profile, based on publicly available information

Julia Tejero-Aranguren

Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada; ECMO Center, Karolinska University Hospital, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ÁEÁngel Estella
Ángel Estella
MCMaria Luisa Cantón
Maria Luisa Cantón
LMLaura Muñoz
Laura Muñoz
IHIsabel Rodriguez Higueras
Isabel Rodriguez Higueras
MNMaría Recuerda Núñez
María Recuerda Núñez
OSon behalf of the Group of Infectious Diseases of the Andalusian Society of Intensive Care and Coronary Units SAMIUC
on behalf of the Group of Infectious Diseases of the Andalusian Society of Intensive Care and Coronary Units SAMIUC
Background: The aim of this study was to analyze the percentage of patients admitted to the ICU having received the vaccine against COVID-19, to describe the clinical profile of vaccinated patients admitted to the ICU, and to assess the humoral immune response to vaccination. Methods: In this multicenter prospective descriptive cohort study, consecutive critically ill patients with confirmed SARS-CoV-2 pneumonia who received at least one dose of the SARS-CoV-2 vaccine were included. The time of study was from 1 July to 10 August of 2021. Results: Of the 94 consecutive patients from seven Andalusian ICUs admitted during the time of study, 50 (53.2%) received at least one dose of anti SARS-CoV-2 vaccine. No patient was admitted having previously had SARS-CoV-2 infection. The B.1.617.2 (Delta) variant was the most frequently identified, in 80.76% of cases. Patients with a complete vaccination with non-optimal antibody levels were immunocompromised. Fifteen patients were admitted to the ICU with Acute Respiratory Distress Syndrome (ARDS) without having completed their vaccination; the clinical profile was younger and with less comorbidities compared to patients with full vaccination. There were no differences in severity of ARDS. Conclusions: Most of the patients who were admitted to the ICU having received a dose of the vaccine were not optimally vaccinated; fully vaccinated patients who did not obtain optimal serum antibody levels were patients considered immunocompromised.

1 March 2023 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
JTJulia Tejero-Aranguren
Julia Tejero-Aranguren
EAEugenia Poyatos Aguilera
Eugenia Poyatos Aguilera
MCManuel Colmenero
Manuel Colmenero
RMRaimundo M García del Moral
Raimundo M García del Moral

14 March 2023 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
JTJulia Tejero-Aranguren
Julia Tejero-Aranguren
EAEugenia Poyatos Aguilera
Eugenia Poyatos Aguilera
MCManuel Colmenero
Manuel Colmenero
RMRaimundo M García del Moral
Raimundo M García del Moral

15 May 2022 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
JTJulia Tejero-Aranguren
Julia Tejero-Aranguren
JRJordi Riera
Jordi Riera
MMMaría Martínez-Martínez
María Martínez-Martínez
EAEduard Argudo
Eduard Argudo
EPElisabeth Papiol
Elisabeth Papiol
RFRicard Ferrer
Ricard Ferrer

1 November 2019 in Medicina Intensiva (English Edition)
Verified
Journal Article
Open access
JAJ. Tejero Aranguren
J. Tejero Aranguren
FFF. Ruiz Ferrón
F. Ruiz Ferrón
MRM. Colmenero Ruiz
M. Colmenero Ruiz

4 June 2026 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
JTJulia Tejero-Aranguren
Julia Tejero-Aranguren
KBKaren E.A. Burns
Karen E.A. Burns
MHMargaret Herridge
Margaret Herridge
HWHannah Wozniak
Hannah Wozniak